| Elizabeth J Pianalto, OTR | |
|
2195 W Chandler Blvd Ste 180, Chandler, AZ 85224-6580 | |
| (480) 963-9339 | |
| (480) 963-4098 |
| Full Name | Elizabeth J Pianalto |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 7 Years |
| Location | 2195 W Chandler Blvd Ste 180, Chandler, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922624089 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OTH-009339 (Arizona) | Primary |
| 225X00000X | Occupational Therapist | OTR3082 (Arkansas) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Stinnett And Scarbrough P.a | 9638073125 | 6 |
| Arizona Center For Hand Surgery Pc | 4880585603 | 26 |
News Archive
The United States Food and Drugs Administration (FDA) has approved Zelboraf (vemurafenib), a drug for the treatment of adults with a are type of blood cancer called Erdheim-Chester Disease or ECD.
A recent study published in the journal Pain in October 2020 adds another piece to the puzzle, showing that the virus is capable of dulling pain pathways. This may contribute to its early and extensive spread.
A team of U.S., Canadian and Italian scientists led by researchers at Johns Hopkins report evidence from studies in animals and humans supporting a link between Alzheimer's disease and chronic heart failure, two of the 10 leading causes of death in the United States.
Impax Laboratories, Inc. confirmed that the U.S. Food and Drug Administration (FDA) has granted tentative approval of the Company's Abbreviated New Drug Application for generic version of Cymbalta® delayed-release (duloxetine hydrochloride) 20, 30 and 60 mg capsules.
An early stage study shows melatonin - a hormone that regulates the body's sleep and awake cycles - may have the potential to help slow the growth of certain breast cancer tumors, according to researchers from Henry Ford Hospital in Detroit and Foundation for Research Support of the State of S-o Paulo.
› Verified 9 days ago
| Provider Name | Stinnett & Scarbrough P.a |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1528016102 PECOS PAC ID: 9638073125 Enrollment ID: O20031125000914 |
News Archive
The United States Food and Drugs Administration (FDA) has approved Zelboraf (vemurafenib), a drug for the treatment of adults with a are type of blood cancer called Erdheim-Chester Disease or ECD.
A recent study published in the journal Pain in October 2020 adds another piece to the puzzle, showing that the virus is capable of dulling pain pathways. This may contribute to its early and extensive spread.
A team of U.S., Canadian and Italian scientists led by researchers at Johns Hopkins report evidence from studies in animals and humans supporting a link between Alzheimer's disease and chronic heart failure, two of the 10 leading causes of death in the United States.
Impax Laboratories, Inc. confirmed that the U.S. Food and Drug Administration (FDA) has granted tentative approval of the Company's Abbreviated New Drug Application for generic version of Cymbalta® delayed-release (duloxetine hydrochloride) 20, 30 and 60 mg capsules.
An early stage study shows melatonin - a hormone that regulates the body's sleep and awake cycles - may have the potential to help slow the growth of certain breast cancer tumors, according to researchers from Henry Ford Hospital in Detroit and Foundation for Research Support of the State of S-o Paulo.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth J Pianalto, OTR 300 W Clarendon Ave Ste 285, Phoenix, AZ 85013-3474 Ph: (602) 277-3686 | Elizabeth J Pianalto, OTR 2195 W Chandler Blvd Ste 180, Chandler, AZ 85224-6580 Ph: (480) 963-9339 |
News Archive
The United States Food and Drugs Administration (FDA) has approved Zelboraf (vemurafenib), a drug for the treatment of adults with a are type of blood cancer called Erdheim-Chester Disease or ECD.
A recent study published in the journal Pain in October 2020 adds another piece to the puzzle, showing that the virus is capable of dulling pain pathways. This may contribute to its early and extensive spread.
A team of U.S., Canadian and Italian scientists led by researchers at Johns Hopkins report evidence from studies in animals and humans supporting a link between Alzheimer's disease and chronic heart failure, two of the 10 leading causes of death in the United States.
Impax Laboratories, Inc. confirmed that the U.S. Food and Drug Administration (FDA) has granted tentative approval of the Company's Abbreviated New Drug Application for generic version of Cymbalta® delayed-release (duloxetine hydrochloride) 20, 30 and 60 mg capsules.
An early stage study shows melatonin - a hormone that regulates the body's sleep and awake cycles - may have the potential to help slow the growth of certain breast cancer tumors, according to researchers from Henry Ford Hospital in Detroit and Foundation for Research Support of the State of S-o Paulo.
› Verified 9 days ago
Sarah J. Whitney, MSOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 575 W Pecos Rd Apt 1127, Chandler, AZ 85225 Phone: 602-793-1492 | |
Taylor Knoll, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3160 N Arizona Ave Ste 105, Chandler, AZ 85225 Phone: 480-365-9981 | |
Kendra Alaine Bauman, O.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1525 W Frye Rd, Chandler, AZ 85224 Phone: 480-812-7000 | |
Mrs. Carole Beth Gates, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6283 W Megan St, Chandler, AZ 85226 Phone: 480-634-4993 | |
Kylie Metherd, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2715 S Alma School Rd Ste 3, Chandler, AZ 85286 Phone: 480-508-5252 | |
Christine Rose Prigge, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 621 N Tercera Ave, Chandler, AZ 85226 Phone: 480-239-1595 Fax: 480-855-3507 | |
Amy Carr, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2175 N Alma School Rd Ste A106, Chandler, AZ 85224 Phone: 480-855-0474 |